Home/Recalls/CANADA-52781
Health CanadaType II

API - Meloxicam, Nystatin, Retinoic Acid, Omeprazole, Liothyronine Sodium, Levot...

Published: February 25, 2015Recall ID: 52781Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

API - Meloxicam, Nystatin, Retinoic Acid, Omeprazole, Liothyronine Sodium, Levothyroxine Sodium (2015-02-13)

Additional Source Details

FieldValue
N I D52781
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/api-meloxicam-nystatin-retinoic-acid-omeprazole-liothyronine-sodium-levothyroxine
IssueProduct safety
Title API - Meloxicam, Nystatin, Retinoic Acid, Omeprazole, Liothyronine Sodium, Levothyroxine Sodium (2015-02-13)
Archived1
CategoryDrugs
Last updated2015-02-25
OrganizationDrugs and health products
Recall classType II

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType II
Official Agency Alert